XML 55 R45.htm IDEA: XBRL DOCUMENT
v3.23.3

Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated | 3 Months Ended
--- | ---
Oct. 31, 2023
Broad Atlantic Associates LLC [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
IDT R.E. Holdings Ltd [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | Israel |
Percentage Owned | 100.00% |
Rafael Holdings Realty, Inc [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
Barer Institute, Inc. [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware | [1]
Percentage Owned | 100.00% |
Hillview Avenue Realty, JV [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
Hillview Avenue Realty, LLC [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
Rafael Medical Devices, Inc. [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 68.00% | [2]
Levco Pharmaceuticals Ltd. [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | Israel |
Percentage Owned | 95.00% | [3]
Farber Partners, LLC [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 93.00% |
Pharma Holdings, LLC [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 90.00% |
LipoMedix Pharmaceuticals Ltd. [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | Israel |
Percentage Owned | 95.00% | [4]
Altira Capital & Consulting, LLC [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 67.00% |
CS Pharma Holdings, LLC [Member] |  |
Description of Business (Details) - Schedule of All Majority-Owned Subsidiaries are Consolidated [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 45.00% | [5]
[1] | In November 2022, the Company resolved to curtail its early-stage development efforts, including pre-clinical research at Barer. The decision was taken to reduce spending as the Company focuses on exploring strategic opportunities.
[2] | In August 2023, the Company raised $925,000 from third parties in exchange for 31.62% ownership of Rafael Medical Devices. As of July 31, 2023, the Company recorded $825,000 of the funds received related to the sale within prepaid expenses and other current assets and other liabilities within the consolidated balance sheets.
[3] | During Fiscal 2022, the Company discontinued further material investment in Levco. In August 2023, Levco was dissolved.
[4] | On February 9, 2023, the Company increased its ownership interest in LipoMedix Pharmaceuticals Ltd. from 84% to 95%.
[5] | 50% of CS Pharma Holdings, LLC is owned by Pharma Holdings, LLC. We have a 90% ownership in Pharma Holdings, LLC and, therefore, an effective 45% interest in CS Pharma Holdings, LLC. The Company, along with CS Pharma and Pharma Holdings, collectively own securities representing 51% of the outstanding capital stock of Cornerstone Pharmaceuticals and 42% of the capital stock on a fully diluted basis. Refer to Note 4 for further details.

X
- References No definition available. + Details
Name: | rfl_DescriptionofBusinessDetailsScheduleofAllMajorityOwnedSubsidiariesareConsolidatedLineItems
Namespace Prefix: | rfl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the major products or services that a subsidiary or equity investee sells or provides and its principal markets, including locations of those markets. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeNatureOfOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_BroadAtlanticAssociatesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_IDTREHoldingsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_RafaelRealtyHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_BarerInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_HillviewAvenueRealtyJVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_HillviewAvenueRealtyLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_RafaelMedicalDevicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_LevcoPharmaceuticalsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_FarberPartnersLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_PharmaHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_LipoMedixPharmaceuticalsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_AltiraCapitalConsultingLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=rfl_CSPharmaHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |